Women with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are more likely to have adverse pregnancy outcomes than the general population.
Women with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are more likely to have adverse pregnancy outcomes than the general population.
There are several therapeutic alternatives and combinations available for inducing remission in ANCA vasculitis. Which of these is your preferred first-line agent?
There are several therapeutic alternatives and combinations available for inducing remission in ANCA vasculitis. Which of these is your preferred first-line agent?
Investigators studied the association of ANCA-associated vasculitis among patients with end-stage kidney disease vs those without end-stage kidney disease.
Investigators studied the association of ANCA-associated vasculitis among patients with end-stage kidney disease vs those without end-stage kidney disease.
Researchers sought to evaluate the rates of serious infections and infection-related deaths during the maintenance period among patients with ANCA-associated vasculitis treated with either rituximab or azathioprine.
Researchers sought to evaluate the rates of serious infections and infection-related deaths during the maintenance period among patients with ANCA-associated vasculitis treated with either rituximab or azathioprine.
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Test your knowledge of the relationship between hyperuricemia and clinical gout. This quiz clarifies key distinctions that impact diagnosis, risk assessment, and treatment decisions in rheumatology practice.
Test your knowledge of the relationship between hyperuricemia and clinical gout. This quiz clarifies key distinctions that impact diagnosis, risk assessment, and treatment decisions in rheumatology practice.
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
